Boos Amends Lexaria Bioscience Stake Filing
Ticker: LEXX · Form: SC 13D/A · Filed: Sep 23, 2024
Sentiment: neutral
Topics: ownership-change, sec-filing, amendment
TL;DR
Boos updated their Lexaria Bioscience stake filing. Watch for more details.
AI Summary
Wayne W. Boos has amended their Schedule 13D filing for Lexaria Bioscience Corp. as of August 31, 2024. The filing indicates a change in beneficial ownership, though specific details on the percentage or number of shares are not provided in this excerpt. The filing is an amendment to a previous Schedule 13D, suggesting ongoing activity or adjustments to Boos's stake in the company.
Why It Matters
This filing signals a potential shift in significant ownership for Lexaria Bioscience Corp., which could influence stock price and corporate strategy.
Risk Assessment
Risk Level: medium — Schedule 13D filings often indicate significant changes in ownership, which can lead to increased volatility and uncertainty for investors.
Key Players & Entities
- Lexaria Bioscience Corp. (company) — Subject Company
- Wayne W. Boos (person) — Filing Person
- Robert B. Goldberg, Esq. (person) — Authorized to Receive Notices
FAQ
What is the specific change in beneficial ownership being reported by Wayne W. Boos?
The provided excerpt does not specify the exact change in beneficial ownership, only that an amendment to Schedule 13D has been filed.
What was the previous filing date for this Schedule 13D?
The excerpt does not state the previous filing date, only that this is Amendment No. 4.
What is the business address of Lexaria Bioscience Corp.?
The business address is 100 - 740 McCurdy Road, Kelowna, A1, V1X 2P7.
Who is authorized to receive notices and communications for this filing?
Robert B. Goldberg, Esq., located at 5555 Glenridge Connector, Suite 675, Atlanta, Georgia 30342, is authorized to receive notices and communications.
What is the CUSIP number for Lexaria Bioscience Corp. common stock?
The CUSIP number for Lexaria Bioscience Corp. common stock is 52886N.
Filing Details
This Form SC 13D/A (Form SC 13D/A) was filed with the SEC on September 23, 2024 by Wayne W. Boos regarding Lexaria Bioscience Corp. (LEXX).